PosterSessionOnline

ISPOR–THE PROFESSIONAL SOCIETY FOR HEALTH ECONOM..

ISPOR Europe 2026

8-11 November Vienna

N. Poster

Poster title

Applicant name

Status


2-MT	Cost Analysis of Continuous Glucose Monitoring (CGM) Policy Changes in Campania, Italy	Dagna Constenla	Received

3-MSR	Impact of Time-to-Event Extrapolation on 36-Month Target Lesion Revascularisation Estimates for Covered Balloon-Expandable Stents in Aortoiliac Occlusive Disease	Kashfa Iqbal	Received

6-MT	KWIT: A digital approach to support COPD screening and monitoring - Results from an innovative approach in France	Thibaut Goulvent	Received

8-SA	Key Considerations for Synthesizing Cross-Country Oncology RWE Transportability Studies	Darren Johnson	Received

8-EE	Cost-Consequence Analysis of Covered Balloon-Expandable Stents Using Extrapolated 3-Year Outcomes for Aortoiliac Occlusive Disease in the UK	Kashfa Iqbal	Received

8-RWD	Validating Self-reported Body Mass Index for Social Desirability Bias in a National Survey Linked with Electronic Health Records	Megan Jones	Received

9-SA	A Systematic Literature Review (SLR) and Indirect Treatment Comparison (ITC) Feasibility Assessment in Homologous Recombination Repair (HRR)-Deficient Metastatic Castration-Sensitive Prostate Cancer (mCSPC)	Neo SU	Received

9-HPR	Role of Real-World Evidence in US FDA Safety Label Modifications - Insights from Case Studies	Anand Jacob	Received

11-EE	Cost-Utility of Early TAVI With the SAPIEN 3 Ultra RESILIA Valve Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A French HTA	Pascal Candolfi	Received

12-HSD	Unlocking the Value of Biologic Therapies in Multiple Myeloma: The Potential of On-Body Injectors to Improve Healthcare Efficiency and Service Delivery	In Hon Henry Fong	Received

14-RWD	Patient Characteristics, Treatment Patterns and Healthcare Resource Utilization in Neuromyelitis Optica Spectrum Disorder (NMOSD) patients in the Netherlands	Naomi Reimes	Received

15-MT	Unlocking guideline adherence: the role of EMR-integrated identification tools in French COPD primary care	Thibaut Goulvent	Received

18-MSR	Automating Briefing Book Development for Major European Health Technology Assessment Submissions Using Generative AI	Saimithra Thammera	Received

19-RWD	Evaluating the Robustness of Time-to-Event Analyses in De-Identified Real-World Dataset Using a Proxy Date of Death Algorithm: A Validation Study in Patients with Multiple Myeloma	Jiani Zhou	Received

20-EPH	Shifts in Treatment Patterns, Healthcare Resource Utilization, and Costs in NMOSD Following Introduction of Approved Therapies Post-2019	Moushmi Singh	Received

21-CO	Network Meta-Analysis (NMA) of Neoadjuvant-Adjuvant Treatment Pathways in HER2+ Early Breast Cancer (EBC) to Inform Cost-Effectiveness	Giorgia Rapesta	Received

21-MT	A Total Cost of Ownership Model to Quantify the Value of RFID Integration in Pre-Filled Syringes	Matthias Borms	Received

22-HTA	Developing Artificial Intelligence-Based Diagnostic Applications in Oncological Imaging: A Structured Expert Elicitation Study to estimate future value propositions	Jamie Verwey	Received

28-HTA	Benchmarking as a Tool for Assessing Cross-Country Comparability of Survival Evidence for HTA	Darren Johnson	Received

29-MT	Short- and Mid-Term Outcomes of TEVAR in Descending Thoracic Aortic Pathologies: Insights From a French Nationwide Cohort	Lucie de Léotoing	Received

29-EPH	Clinical Under-Recognition of Severe Hypertriglyceridemia Patients in Real World Practice: Insights from ICD Coding and Triglyceride Levels	Miriam Souto	Received

30-SA	Comparison of Patient Characteristics and First-Line Treatment Patterns in Metastatic NSCLC: US and Finland Cohorts to Inform Overall Survival Transportability Analyses	Darren Johnson	Received

31-RWD	Real-World Treatment Patterns, Adherence, and Healthcare Resource Use After Clinical Trial Participation in Women With Vasomotor Symptoms: Evidence From the OASIS STAR Linked Dataset	Lena Charafi	Received

32-SA	Early Network Meta-Analysis in Generalized Myasthenia Gravis Using Time-Course Adjustment Through Model-Based Network Meta-Analysis	Saimithra Thammera	Received

35-MT	Assessment of a Digital Medical Gas Management Platform: Insights from Healthcare Professionals on Workflow Efficiency, Safety, and Healthcare Resource Optimization in Italy	Alessandra Piemontese	Received

37-RWD	Intercountry comparison of the Real World Data accessibility in Asia and Beyond: progress and challenges	Sabrina de Souza	Received

38-RWD	A Global AI-Driven Code List Generation Tool with Integrated Japanese Medical Dictionary for Scalable Cross-Country Real-World Evidence	Luis Vaz	Received

38-MT	Cost-Utility Analysis of Closed Loop Stimulation Pacemakers versus Conventional Rate-Adaptive Pacing in the United Kingdom	Mikhail Kukushkin	Received

39-RWD	Representativeness of Broad-Consent Real-World Data: A Cross-Sectional Analysis of 3.5 Million Inpatients in the Helios Safe Medical Data Platform	Sabine Spaenig	Received

40-RWD	Long and Complex Femoropopliteal Segment Lesion Treatments in France: An Analysis of the French National Hospital Discharge Database	Lucie de Léotoing	Received

41-CO	Leveraging Specialist Ophthalmology EMR Data to Evaluate Real-World Effectiveness of Anti-VEGF Therapies for Diabetic Macular Edema	Mark Yates	Received

42-EE	Economic Break-Even of Capacity-Reservation Models for Antiviral Pandemic Preparedness in Germany	Svenja Schwarz	Received

50-SA	Investigating the Correlation Between Progression-Free Survival (PFS) and Overall Survival (OS) in first-line (1L) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).	Enrico de Nigris	Received

54-PCR	Health State Utilities Before and After Revascularization for Atherosclerotic Cardiovascular Disease: A Systematic Literature Review and Meta-Regression Analysis	Vishal Bali	Received

55-PCR	Health utility values measured by EQ-5D in patients with post-stroke hemiplgia: a systematic review and meta-analysis	SOOBIN JANG	Received

58-EE	Economic Impact Of Embolic Agent Choice (Liquid Vs Particles) In Middle Meningeal Artery Embolization For Chronic Subdural Hematoma : A National Healthcare System Perspective	FRANCESCA MARIANI	Received

58-RWD	Real-World Utilization of Talazoparib Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer in the United States	Neo Su	Received

59-RWD	Gaining Efficiency in the integration of a Multimodal Oncology Real-World Data source into an Enterprise Analytics Platform	Sabrina de Souza	Received

61-PCR	Adult Phenylketonuria Multidimensional Burden of Illness: A Qualitative Study	Zoe Wagg	Received

66-HSD	From Ambiguity to Agreement: Strengthening eDelphi Consensus Through Rigorous Survey Instrument Design	Megan Jones	Received

67-EPH	Epidemiology and Outcomes of Chronic Hepatitis B in Brazilian Adults: A Nationwide Analysis, 2010-2025	Jacqui Tan	Received

75-RWD	Improving Identification of Patients, Caregivers, and Healthcare Professionals in Social Media Data Using Fine-Tuned Pretrained Language Models in French and English	Stéphane Schück	Received

78-HSD	Real-World Drivers of Clinical Decision-Making in Atrial Fibrillation: Understanding Subjective Reasons for Non-Initiation of Oral Anticoagulants	Sandra Cusco	Received

79-SA	Evaluating the Feasibility of Indirect Treatment Comparisons in Patients with epNEC Treated in Second-Line and Beyond (2L+): A Guideline-Informed Systematic Literature Review and Feasibility Assessment	Karolin Eberle	Received

83-PCR	Systematic Literature Review of Treatment Preference Elicitation Studies in Sickle Cell Disease	George Morgan	Received

85-RWD	Description and Burden of Portal Hypertension Treatments in France: A National Hospital Database Analysis	Lucie de Léotoing	Received

85-EPH	Burden of HPV-related cancers in Europe: incidence across 27 countries	Ugne Sabale	Received

87-EPH	Characteristics and Treatment Patterns of Patients with Spinal Muscular Atrophy in the United States	Crystal Watson	Received

89-HPR	Managed Entry Agreements (MEAs) in Greece: Stakeholder Perspectives on Outcome-Based Reimbursement and Healthcare System Readiness	IOANNIS GASIAS	Received

89-HSD	Exploring the Future Treatment Landscape of Relapsed/Refractory Multiple Myeloma (RRMM): How Clinical Trial Line of Therapy (LoT) Eligibility May Reshape Treatment Sequencing	Steven Banks	Received

89-PCR	Real-World Behavioral Clustering Reveals Three Actionable patients with COPD throughout Archetypes for Tailored Interventions	Thibaut Goulvent	Received

91-SA	A Pragmatic Cluster-Randomized Real-World Study of Biologic Therapy in Inflammatory Bowel Disease in a US Community Gastroenterology Network	Nicholas Lazarou	Received

92-CO	The incidence of kidney failure and the impact of proteinuria in people with IgA nephropathy: A systematic review and meta-analysis	Antonio Ramirez de Arellano	Received

93-HPR	Assessing the Potential Impact of U.S. Most-Favored-Nation Pricing Models on Innovative Drug Launches in Czechia	ARIEL HAMMERMAN	Received

93-HSD	Exploring barriers to shared decision-making (SDM) in rare diseases from the physician perspective in Europe: findings from a cross-sectional survey	Megan Jones	Received

98-SA	The CAPTURED Trial: Can algorithms and quality Improvement support for primary care lead to earlier diagnosis for specific rare disease patients?	David Price	Received

98-HTA	Can AI-Assisted SLRs Meet HTA Standards? Evidence From a NICE Single Technology Appraisal	Hannah Harrington	Received

99-HTA	A Review of SACT Data Used in NICE Technology Appraisals	James Gould	Received

100-HSD	A Budget-Neutral Utilization-Credit Incentive to Improve Operating Room Capacity Management: A Pre-Post Study	Melana Elliot	Received

101-MSR	Automated Quality Control of Health Economic Excel Models Using a Large Language Model Agent: A Multi-Model Validation Study	Andre Verhoek	Received

101-HTA	A Structured Multi-Criteria Decision Framework for Global Launch Prioritization of Innovative Oncology Medicines: A Conceptual Methodology	Kalman Wijaya	Received

113-HPR	Biosimilar-Enabled Access and Repositioning (BEAR): A Framework for Lifecycle Assessment and Repositioning of Biologic Therapies Informed by Cross-Country Evidence and Stakeholder Recommendations	Natasha Jackson	Received

113-PCR	Evolution of Social Media Conversations About Obesity and GLP-1 Treatments in France Between 2016 and 2026 : A Social Listening Study	Nathalie Texier	Received

115-CO	Prognostic Impact of RAS/KRAS Mutation Status on Survival Outcomes in First-Line Metastatic Colorectal Cancer: A Systematic Literature Review	Bjoern Stollenwerk	Received

116-EPH	Estimating the Global Prevalence of Turner Syndrome: A Systematic Literature Review and Meta-Analysis	Laura Cahill	Received

118-HSD	Attitudes Towards Patient-Centered Rare Disease Care Among Physicians in Five European Countries: A Cross-Sectional Survey	Megan Jones	Received

118-RWD	Real-World Utilization, Expenditures, and Cardiovascular Events Among Users of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in US Adults With Type 2 Diabetes	Albaraa Alwafi	Received

118-PCR	Domain-Specific Factors Associated With Mental, Physical, and Global HRQoL Among Adults Reporting Depression in the EU5	Megan Jones	Received

119-HTA	Obtaining Key Estimates of Resource Use Associated with Hidradenitis Suppurativa Management: Results from a UK-Based Online Delphi Study	Louise Longworth	Received

124-CO	Comparative Effectiveness of Afami-cel in Synovial Sarcoma Using Unanchored Matching-adjusted Indirect Comparisons	Noemi Hummel	Received

126-HTA	Beyond Validation: A Conceptual Framework for Digital Endpoint Reimbursement & Assessment	Artem Boltyenkov	Received

127-HSD	Artificial Intelligence And Health Inequity: A Targeted Literature Review Of Bias Arising From Historical Healthcare Data (2020-2026)	Tanha Ahmed	Received

129-EE	The Cost-Effectiveness of Imlifidase for Desensitisation Treatment of Highly Sensitised Adult Kidney Transplant Patients in Spain	Ferran Perez	Received

130-PCR	Establishment of the Importance of and Meaningful Change in Physical Activity in Patients with Cancer Cachexia; a DHT-Measurable Concept	Leila Lackey	Received

131-HPR	Institutional Implementation of ESMO-MCBS Value Assessment in Oncology Formulary Management: A Tertiary Healthcare System Study	Laila Carolina Abu Esba	Received

135-PCR	Researching the Burden of Netherton Syndrome: A Systematic Literature Review	George Morgan	Received

136-HPR	Five Years of the FIFARMA W.A.I.T. Indicator: A Longitudinal Analysis of Oncology and Orphan Drug Access in Latin America (2022-2026)	Carmen Silvana Lay Ma	Received

140-PCR	Impact of Comorbidity Burden on Long-Term Quality of Life Following Severe Viral Lower Respiratory Tract Disease Hospitalisation	Rebecca Hardy-Woods	Received

143-HPR	The Evolving Access and Policy Concerns of Global Pharmaceutical Manufacturers: An Analysis of Challenges and Policy Solutions Identified in Manufacturers´ Comments in Response to International Reference Price-Based Proposals	Emma Hammer	Received

145-HPR	Impact of Measurement Error and Differential Misclassification on Assessments of Hospital-Based Surgical Quality	David Etzioni	Received

148-EPH	Increased rates of emergency care in people with idiopathic inflammatory myopathies: A population-based cohort in England 2002 to 2021	Charlotte Curtis	Received

148-PCR	Preferences and Willingness-to-Pay for Lyme Disease Vaccines in the United States: A Latent Class Approach	MARCO BOERI	Received

149-CO	Health-Related Quality-of-Life in Patients with Rare Mold Infections: EQ-5D-5L Results from a Phase IIb Trial Evaluating Olorofim in Adults with Invasive Fungal Infections and Limited or No Treatment Options	Craig Coleman	Received

150-MSR	Impact of Estimand Misalignment in Indirect Treatment Comparisons of Oncology Trials with Treatment Switching - A Simulation Study	Thilo Welz	Received

151-PCR	Beyond Patient Outcomes - The Growing Recognition of Caregiver Impact in Outcomes Research	Céline Desvignes-Gleizes	Received

153-PCR	Standardizing Personalized Outcome Assessment with Goal Attainment Scaling: Reliability of a Structured Goal Appraisal Framework and Evaluation of AI-Assisted Review	Rebecca Metcalfe	Received

154-HPR	Dual brand strategy in German drug pricing: limited opportunity based on AMNOG framework with exceptions?	Lina Hohmann	Received

157-MSR	The Sensitivity Analysis Paradox in Target Trial Emulation: An Empirical Taxonomy of Bias Mitigation and Protocol Design in 208 Studies	Alban Fabre	Received

158-MSR	An LLM Agent Builds a Functional Cost-Effectiveness Model in Excel with Live Formulas and VBA Macros from a Written Specification: A Novel Architectural Approach	Andre Verhoek	Received

159-MSR	MAPPING FOUNDATIONAL DECISION-AI METHODS IN HEALTH ECONOMIC EVALUATION: A SCOPING REVIEW	Archita Sarmah	Received

159-PCR	Patient Reported Outcomes Associated With Non-Treatment: A Real-World Outcomes Evaluation of Atrial Fibrillation Patients Not Receiving Oral Anticoagulation	Ali Siddiqui	Received

159-HTA	From Medical Writer to Medical Editor: Redefining the Role of HTA Professionals in the Age of AI-Assisted Document Development	Katharina Hoffmann	Received

163-HPR	ASSESSING THE IMPACT OF US MFN POLICY ON EMA APPROVAL TIMING FOLLOWING FDA APPROVAL: AN EXPLORATORY ANALYSIS	Tracey Tingle	Received

165-PCR	A Social Media Listening Analysis of Perceived Health Improvements Associated with Glucagon-like Peptide-1 (GLP-1) Use Beyond Weight-loss and Diabetes-focused Communities	Megan Jones	Received

167-EPH	Impact of baseline comorbidities and combinations of comorbidities among people with type 2 diabetes on health care resource utilisation in the UK	TARIQ HALASA	Received

168-MSR	Evaluation of an AI-augmented literature review platform in targeted literature reviews - a practical industry HEOR perspective	Jack Timmons	Received

170-PCR	Health Utility and Work Productivity Burden Associated With Co-Occurring Anxiety and Chronic Pain Among Adults Reporting Depression in the EU5	Megan Jones	Received

173-HPR	Tackling Socioeconomic Inequalities Associated With Meningitis And Encephalitis And The Role Of Rapid Multiplex Testing	Hayden Holmes	Received

173-EPH	Untreated risk of hospitalization and death among high-risk patients with mild-to-moderate COVID-19 in the United States: a systematic literature review update	David Campbell	Received

173-RWD	Cross-Country Differences in Real-World Laboratory Monitoring Intensity and Hepatotoxicity Adverse Event Detection Among Initiators of CDK4/6 Inhibitors for Advanced Breast Cancer	Darren Johnson	Received

176-RWD	Closing Gaps in Real-World Evidence: Unlocking Clinical Value from Unstructured EHR Notes	Zuzana Dostalova	Received

177-HTA	A MULTI-SCALE CLASSICAL AI FRAMEWORK FOR SYSTEM-LEVEL VALUE ASSESSMENT OF HEALTH TECHNOLOGY ADOPTION	Archita Sarmah	Received

178-PCR	Patient Preferences in Neuromyelitis Optica Spectrum Disease (NMOSD): A Swing Weighting Study	Moushmi Singh	Received

179-PCR	Patient Experience With Bladder-Sparing Therapy in Muscle-Invasive Bladder Cancer: A Targeted Literature Review	Allison Thompson	Received

179-HTA	Methods for modelling immature overall survival (OS) in breast cancer (BC) in National Institute for Health and Care Excellence (NICE) technology appraisals (TAs)	Chloe Spalding	Received

180-EE	Estimating Individual-Level Medical Cost Savings from Digital Chronic Disease Management: A Biometric-to-PMPM Proxy Methodology	Yifat Fundoiano-Hershcovitz	Received

185-PCR	How Does Cachexia Influence Health-Related Quality of Life Burden Among Adults with Solid Tumor Cancers in the United States and Europe?	Patrick Hlavacek	Received

191-HTA	Strengthening Comparative Evidence for HTA: A Structured causal framework for confounder identification	Sophie Wang	Received

192-MSR	Automating R Shiny Cost Effectiveness Models for Stroke Using a Multi Agent AI Framework: Development and Validation	Sridhar Banerjee	Received

199-EPH	Structural Patient Safety Failures in Non-Medical Aesthetic Settings: Evidence From a Nationwide Dermal Filler Inspection Program in Switzerland to Inform Risk-Based Regulatory Policy	Anita Kuduzovic	Received

203-PCR	Multi-country Content Validation of the EQ-5D-5L + 4 Bolt-on Items Within Non-segmental Vitiligo	Louise Longworth	Received

205-MSR	Investigation of the benefit of using an OS-prognostic biomarker for early decision making in oncology	Tim Becker	Received

206-EE	Health utility values measured by EQ-5D in patients with Parkinson´s disease: a systematic review and meta-analysis	SOOBIN JANG	Received

207-MSR	Feasibility Assessment of Network Meta-Analysis in Generalized Myasthenia Gravis: Methodological Challenges From a Rapid Evidence Review	Sridhar Banerjee	Received

210-PCR	How can we Approach Whole Health Using Digital Biomarkers and Endpoints from Consumer Wearables?	Annette Champion	Received

211-PCR	A Review of Goal Attainment Scaling Implementation and Reporting in Clinical Trials over the Last Decade	Rebecca Metcalfe	Received

213-HTA	Residual Confounding in Real-World External Control Arms: An Updated NICE Appraisal Review	Cormac Sammon	Received

215-HPR	MFN Shockwaves Beyond the US: Evidence of Accelerated German Launches, Selective Non-Entry	Costanza Alciati	Received

217-HTA	Patient Involvement in HTA Across the EU4 and UK: A Mapping of Access Points and Influence Across HTA Milestones	Evelien de Wilt	Received

218-CO	Understanding Unmet Need in the Contemporary Treatment Landscape in a European Generalized Myasthenia Gravis Population from both Physician and Patient Perspectives: A Real-World Study	Sanal Simon	Received

224-PCR	Food Noise During Glucagon-like Peptide-1 (GLP-1) Maintenance: A Social Media Listening Analysis of UK Patient Communities	Megan Jones	Received

229-PCR	Health-Related Quality of Life Burden Associated With Past-Year Depression in the EU5: A Matched National Health and Wellness Survey Analysis	Megan Jones	Received

231-HPR	Balancing Ambition and Reality -The Shifting International Landscape of Performance-Based Managed Entry Agreements	Emma Kent	Received

231-PCR	Health-Related Quality of Life in Patients with Chronic Diseases. A Targeted Literature Review of the Impact of Chronic Diseases in Spain and Europe	Ada Pelaez	Received

236-HPR	EARLY IMPACT OF MOST FAVOURED NATION (MFN) POLICY ON REIMBURSEMENT DECISIONS, LAUNCH ACTIVITY, AND MARKET ACCESS IN SWEDEN	Azad Saei	Received

240-EE	Early Economic and Pathway Impact of Incorporating Novel Mass Spectrometry-Based Testing into Treatment Response Assessment for Multiple Myeloma	Gregory Price	Received

241-EE	Age of disease causal human papillomavirus (HPV) infection for oropharyngeal cancer in Finland and Poland: a modeling study	Ugne Sabale	Received

244-PCR	Determining meaningful within-patient change thresholds for GODDESS outcomes in the Phase 3 RINGSIDE Part B trial	Samantha Fowkes	Received

244-EPH	Real-World Burden of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Italy: Epidemiology, Treatment Patterns, and Healthcare Costs	Lisa Giannessi	Received

246-HTA	Expanded Value Measures through Behavior Change: An International Delphi Consensus on Reimbursement of Digitally Enabled Behavioral Interventions	Andrew Kwist	Received

246-MSR	Internally Validated Prediction of Severe Health Utility Impairment Among Adults Reporting Depression in the EU5	Megan Jones	Received

249-PCR	Health-Related Quality of Life and Health-state Utilities in IgA Nephropathy: A Systematic Literature Review	Mark Pletscher	Received

249-MSR	A Hybrid AI-Assisted Screening Framework for Systematic Literature Reviews in Acute Ischaemic Stroke-Large Vessel Occlusion: Efficiency and Accuracy	Sanal Simon	Received

250-EE	Long-term economic impact of gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia B in Spain	Miquel Sastre-Belío	Received

251-EPH	Health outcomes by Chronic Obstructive Pulmonary Disease (COPD) diagnosis status and risk level: findings from the EU National Health and Wellness Survey	Megan Jones	Received

256-HTA	Capturing the Patient Perspective: Targeted Literature Review Findings on the Critical Role of PROs in Oncologic AMNOG Evaluations	Caroline Protze	Received

257-PCR	Measurement Properties of the Patient-Reported Impact of Dermatological Diseases (PRIDD): A Global Study of Patients with Alopecia Areata	Allison FitzGerald	Received

259-PCR	Clarity Through Contrast: Elevating Stakeholder Insights from eDelphi Methods with a Patient-Centered Multi-Panel Design	Megan Jones	Received

259-EE	Healthcare Resource Utilization in Patients with Severe Asthma treated with tezepelumab in Spain. Insight from the T-ROSS II study	Marta Alegria	Received

261-PCR	Translation Quality as an Underrecognized Determinant of Data Validity in Multinational HEOR: A Conceptual Framework	Alexander Vareiko	Received

262-EE	Economic Positioning Of Surgery With Absorbable Steroid-Eluting Sinus Implants Versus Dupilumab In Severe CRSwNP : An Italian National Health Service Payer Perspective	Elisa Tacconi	Received

263-MSR	Extending the Validation of Accuracy for Large Language Model (LLM)-/Machine Learning (ML)-Extracted Information and Data (VALID) Framework Globally: Quality Assessment of LLM-Derived Prostate Cancer Real-World Data in the UK	Darren Johnson	Received

264-HTA	Exploring the Impact of Evolving Treatment Pathways on Comparator Relevance in European Oncology Health Technology Assessments (HTAs)	Evelien de Wilt	Received

265-MSR	From Real-World Data (RWD) to In-Silico Design: An Integrated Approach to Optimise Study Design and Decision Making	Saimithra Thammera	Received

275-EE	Budget Impact Analysis of Obinutuzumab for Active Lupus Nephritis from the Brazilian Private Healthcare System Perspective	Natalia Bergamelli Ramos	Received

280-MSR	Performance of Nested Knowledge Criteria-Based Screening and Adaptive Smart Tagging Against a Manually Conducted Systematic Literature Review in Hereditary Angioedema	Trisha Whitney	Received

291-MSR	Challenges for the Economic Evaluation of Diagnostic Technologies: a Review and Taxonomy	Ulises Garay	Received

294-EE	An End-to-End LLM Pipeline for Health Economic Technical Reports: Rights-Verified Sources, Expert-Approved Drafting, and Hallucination-Free Citations	Andre Verhoek	Received

306-HTA	Current and Future Adoption of Artificial Intelligence by European Payers	Jordi Coste Pradas	Received

313-HTA	Organizational Impacts in Health Technology Assessment: A Decision Framework for Evidence Generation	Olivier Marcellin	Received

314-EE	Cost Effectiveness and Health Care Resource Utilization of Pre-emptive Use of TIPS with Controlled Expansion for High-Risk Patients with Variceal Bleeding in Italy	Geraldo Tadinho Monteverde Spencer	Received

316-HTA	The Rise of China - Are Chinese Medicinal Products Successfully Launching in Europe?	Paula Skowron	Received

319-EE	Test, Target, Treat: Cost-Effectiveness of hsCRP-guided treatment in people with atherosclerotic cardiovascular disease and chronic kidney disease in Sweden	Phillip Kittel	Received

322-EE	Economic Burden of Obesity: Real-World Data from the Greek Private Healthcare Sector	KATERINA VOGIATZI	Received

324-HTA	Should The Efficiency Verdict Depends On The Chosen Reference Value? A Retrospective Analysis Of 2025 French CEESP Cost-Effectiveness Opinions	Stéphane Roze	Received

330-EE	Lifetime Cost of Care Simulation of Compensated Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis	Yestle Kim	Received

333-EE	Quantifying the Societal Value of Resmetirom For Metabolic Dysfunction Associated Steatohepatitis Using a Societal Value Modeling Approach	Yestle Kim	Received

334-EE	The Impact of Semaglutide on Hospitalization and Healthcare Costs in Israel	Udi Moshel	Received

344-EE	Cost-effectiveness of oral nirmatrelvir-ritonavir in patients at high risk for progression to severe COVID-19 in the United States	David Campbell	Received

350-HTA	HTA Bodies Request Fewer Than 50% of Guideline-Defined PICOs: Evidence from Eight EU Markets and Lessons for EU JCA	Paula Skowron	Received

352-EE	Cost-per-Response of Advanced Therapies in Spondyloarthritis From the Perspective of the Brazilian Private Healthcare System	Thiago Marchesan	Received

367-HTA	Teprotumumab for Thyroid Eye Disease: UK Key Opinion Leader Perspectives to Inform a NICE HTA Strategy	Salimah Champsi	Received

404-HTA	Current GenAI Policy In HTA: The Missing Mandate And Implications For Industry	James Woolnough	Received

419-EE	Economic and Operational Impact of a Fully Digital Diagnostic Pathway for Obstructive Sleep Apnoea in the NHS: A Time-Driven Activity-Based Costing Analysis	Ankit Ghildiyal	Received

444-EE	Public Health and Economic Impact of Bivalent RSVpreF Vaccination Among Adults in Denmark	Mary MacKinnon	Received

452-EE	Advancing Standardization in Digital Health: Integrating PICOTS-ComTeC and CHEERS-DHI to Improve Evaluation, Reporting, and Economic Assessment	Carl Asche	Received

463-EE	The economic burden of syncope and specialist unit costs: a UK scenario and break-even analysis	Cristiana Monteiro	Received

466-EE	Cost-Consequence Analysis of Covered Balloon-Expandable Stents with Published 3-Year Outcomes for Aortoiliac Occlusive Disease in the UK	Kashfa Iqbal	Received

484-EE	Nationwide Direct Healthcare Cost Burden of Documented Metabolic Syndrome in Slovakia: A Population-Based Cohort Study Using Administrative Healthcare Data	Tomas Mesaros	Received

516-EE	Evaluating the Economic Impact of Adopting Selinexor-Based Therapy for Relapsed/Refractory Multiple Myeloma (RRMM) in Qatar	Nancy Chidel	Received

520-EE	The economic burden of Early-Stage HR+/HER2- Breast Cancer (BC) in Spain. A Cost-of-illness Study	Laura Ricou Ríos	Received

537-EE	Cost Impact of Tafasitamab combined with lenalidomide and rituximab in relapsed or refractory follicular lymphoma: a Time to next treatment and number needed to treat based pharmacoeconomic analysis.	Bruno A Marques	Received

562-EE	Trajectories and Composition of Costs Across Disease Progression Stages in Duchenne Muscular Dystrophy: A Systematic Review	Silene Giusti	Received

639-EE	Progression of Metabolic Dysfunction-Associated Steatohepatitis and Economic Burden: Use of Real-World Health Record Data in England to Inform Economic Models	Yestle Kim	Received

665-EE	Budget-Impact Analysis of Tividenofusp Alfa; a Blood-Brain Barrier-Crossing Enzyme Replacement Therapy for the Treatment of Mucopolysaccharidosis Type II in Pediatric Patients with Neurologic Symptoms	Camille Baker-Smith	Received

680-EE	A gateway to future innovations: Real Option Value (ROV) of first-line CDK4/6 Inhibitors in HR+/HER2-negative Metastatic Breast Cancer	Kristen Migliaccio-Walle	Received

686-EE	Momelotinib results in cost savings vs ruxolitinib for patients with myelofibrosis and moderate to severe anaemia	Jacob Gehrman	Received

716-EE	Economic Impact of Recombinant Activated Factor VII Prophylaxis in Severe Glanzmann Thrombasthenia: A Prospective Cohort Analysis from Saudi Arabia	George Morgan	Received

734-EE	Review of NICE Submissions and Comparison of Economic Model Structures and Methodological Precedent in Retinal Diseases	Hannah Baker	Received

ISPOR Europe 2026

8-11 November Vienna

Help Line

Homepage

Personal Area

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 08/11/2026 TO 08/11/2026

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions